Nitric Oxide Completed Phase 2 Trials for Acute Chest Syndrome / Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01089439Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children